Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
225 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (11)
  • (-) Currently Recruiting (3)
  • Closed (8)

Medical Condition

  • Show all (225)
  • Addiction (4)
  • Allergy, Asthma, & Immunology (1)
  • Autoimmune Disorders (3)
  • Bone & Muscle (2)
  • Cancer (10)
    • Breast Cancer (2)
    • Gynecologic Cancer (1)
    • Leukemia (3)
    • Liver Cancer (1)
    • Lymphoma (1)
    • (-) Pancreatic Cancer (1)
  • COVID-19 (Coronavirus) (8)
  • Diabetes (7)
  • Ear, Nose and Throat (7)
  • Endocrine & Metabolic Disease (2)
  • Gastrointestinal and Digestive Diseases (3)
  • Hair and Skin Disorders (1)
  • Healthy Volunteers (44)
  • Heart Disease (21)
  • Infectious Disease (10)
  • Insomnia (1)
  • Liver Disease (12)
  • Lung Disease (2)
  • Neurological Disorders (31)
  • Nutrition (2)
  • Obesity (8)
  • Obstetrics & Gynecology (9)
  • Pediatrics (14)
  • Psychiatric Disorders (6)
  • Rehabilitation (2)
  • Stroke (2)
  • Transplant (12)
    • (-) Kidney Transplant (2)
    • Liver Transplant (8)
  • Vascular Conditions (1)
Displaying 1 - 3 of 3

The Cancer of the Pancreas Screening-5 Study (CAPS5 Study)

Condition: Cancer / Pancreatic Cancer
Investigator: Fay Kastrinos, MD
Status: Currently Recruiting
Pancreatic cancer is a deadly disease and the best hope for improving the chances of survival is to find it early. Some patients, called "high risk", have an inherited predisposition to pancreatic cancer. Certain medical centers have started programs where "high risk patients" undergo testing, such as receiving imaging scans, to look for…
Read More

A study to investigate the efficacy and safety of frexalimab versus tacrolimus in adults undergoing kidney transplantation

Condition: Transplant / Kidney Transplant
Investigator: Lloyd Ratner, MD, MPH, FACS
Status: Currently Recruiting
This study is testing whether a new investigational medicine called frexalimab can safely and effectively prevent kidney transplant rejection compared to tacrolimus, a standard medication currently used after transplant. Participants will be randomly assigned to receive either frexalimab (given by injection every 4 weeks) or tacrolimus (taken as capsules…
Read More

VEL-101 (VELOXIS) to Prevent Rejection After Kidney Transplantation

Condition: Transplant / Kidney Transplant
Investigator: Lloyd Ratner, MD, MPH, FACS
Status: Currently Recruiting
The main goal of this clinical trial is to determine if an investigational medication called VEL101 is safe, well tolerated, and effective in people receiving a new kidney transplant. Participants will be randomly assigned to 2 different doses of VEL-101 or to tacrolimus, which is standardly used post-transplant to prevent rejection. Participants will be…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science